Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lessons from UK prospective diabetes study

R C Turner1, R R Holman

  • 1Diabetes Research Laboratories, Radcliffe Infirmary, Oxford, United Kingdom.

Diabetes Research and Clinical Practice
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Australian guidelines for anal cancer screening using anal human papillomavirus testing with cytology triage in people living with HIV.

HIV medicine·2025
Same author

[Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. (A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes)].

Problemy endokrinologii·2019
Same author

Modelling incremental benefits on complications rates when targeting lower HbA<sub>1c</sub> levels in people with Type 2 diabetes and cardiovascular disease.

Diabetic medicine : a journal of the British Diabetic Association·2017
Same author

Continuous glucose monitoring detected hypoglycaemia in the Treating to Target in Type 2 Diabetes Trial (4-T).

Diabetes research and clinical practice·2017
Same author

Effect of metformin therapy on circulating amino acids in a randomized trial: the CAMERA study.

Diabetic medicine : a journal of the British Diabetic Association·2016
Same author

Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2015
Same journal

Cognitive frailty in diabetic patients: A visual analysis based on CiteSpace.

Diabetes research and clinical practice·2026
Same journal

Prevalence, incidence, and 6-years stability of metabolically unhealthy normal weight́s phenotype in u.s. hispanic/latino adults.

Diabetes research and clinical practice·2026
Same journal

Corrigendum to "Association between interleukin-6, suPAR, and hsCRP with subclinical left ventricular dysfunction in type 1 diabetes: The Thousand & 1 study" [Diabetes Res. Clin. Pract. 222 (2025) 112071].

Diabetes research and clinical practice·2026
Same journal

Health-related quality of life and management routine in painful and painless diabetic polyneuropathy (PREDIP study).

Diabetes research and clinical practice·2026
Same journal

Impact of glucagon-like peptide-1 receptor agonists with guideline-directed medical therapy in patients with heart failure with reduced ejection fraction and type 2 diabetes.

Diabetes research and clinical practice·2026
Same journal

Independent and combined effects of first-trimester elevated fasting blood glucose and high-normal blood pressure on pregnancy outcomes.

Diabetes research and clinical practice·2026
See all related articles

Intensive treatment for Type II diabetes may prevent complications. The UK Prospective Diabetes Study (UKPDS) investigates if better glucose control and specific therapies reduce long-term health issues in diabetic patients.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Clinical Trials

Background:

  • Type II diabetes significantly increases risks for cardiovascular disease and diabetic complications.
  • Current treatment often focuses on preventing severe hyperglycemia, accepting moderately elevated glucose levels.
  • Uncertainty exists regarding the benefits of intensive glucose control in Type II diabetes.

Purpose of the Study:

  • To determine if intensive glucose control in Type II diabetes delays clinical complications.
  • To assess if specific therapies (sulfonylurea, metformin, insulin) offer advantages or disadvantages.
  • To evaluate the overall impact of improved glycemic control on morbidity and mortality.

Main Methods:

  • The UK Prospective Diabetes Study (UKPDS) is a randomized trial involving 4209 newly diagnosed Type II diabetic patients.

Related Experiment Videos

  • Patients are allocated to various treatment strategies, including diet, oral agents, and insulin.
  • Outcomes measured include the onset of microvascular and macrovascular complications, and specific therapy effects.

    • Main Results:

    • The Diabetes Control and Complications Trial (DCCT) showed intensive therapy reduced microvascular disease in Type I diabetes.
    • The UKPDS aims to establish if similar benefits apply to Type II diabetes, where cardiac disease is a primary concern.
    • The study will identify potential harms or benefits associated with different therapeutic agents.

    Conclusions:

    • Intensive glycemic control may be beneficial in preventing or delaying diabetic complications in Type II diabetes.
    • Identifying optimal therapeutic strategies is crucial for managing Type II diabetes and reducing associated risks.
    • Further research is needed to confirm the long-term efficacy and safety of various treatment regimens.